Nasopharyngitis is the clinical name for the common cold, an acute viral infection of the nose and throat that ranks among the most frequent illnesses humans experience. Children come down with up to five colds a year, and adults average two to three, with most symptoms clearing within a week though coughs often linger longer.1PubMed Central. Common cold Despite being medically mild, the sheer volume of cases makes nasopharyngitis one of the most economically and socially disruptive conditions in modern life.
Why Your Nose Runs and Your Throat Hurts
A common misconception is that the cold virus directly destroys tissue in your nose and throat, and that is what makes you feel terrible. The reality is more indirect. When a rhinovirus or similar pathogen infects the lining of your upper airway, your own immune system generates most of the misery. The infected cells trigger a local inflammatory response that releases chemical messengers, including one called bradykinin, which is produced when an enzyme from epithelial cells converts a precursor protein in your blood plasma. Bradykinin stimulates nerve endings and drives the runny nose, congestion, and sore throat that define a cold.2PubMed Central. Comparative nasal effects of bradykinin and histamine: influence on nasal airways resistance and plasma protein exudation Systemic symptoms like fatigue and achiness come from a separate set of signals, mainly cytokines released by white blood cells mounting a broader defense. So when you feel beaten up by a cold, you are largely feeling your own immune response at work.
Diagnosis Is Almost Entirely Clinical
Most people never get a lab test for a cold, and they do not need one. Doctors diagnose nasopharyngitis based on the familiar cluster of symptoms: runny nose, sneezing, sore or scratchy throat, mild congestion, and possibly a low-grade fever. The main diagnostic challenge is separating a cold from influenza, which tends to hit harder and faster with high fever, severe body aches, and profound fatigue.3PubMed Central. Upper Respiratory Infections COVID-19 complicated this picture further, since early symptoms can overlap with a cold. But for the vast majority of otherwise healthy people, the clinical pattern is distinctive enough that no swab or blood draw is necessary.
That said, rapid multiplex testing, which can identify dozens of respiratory viruses from a single swab, is becoming more common in emergency departments. One prospective evaluation found that patients with a confirmed viral diagnosis were far less likely to receive unnecessary antibiotics than patients whose pathogen went unidentified. The testing group also spent significantly less time in the emergency department.4PubMed Central. Point‐Of‐Care Respiratory Diagnosis and Antibiotic Utilization in the Emergency Department: A Prospective Evaluation of Multiplex PCR A systematic review of rapid multiplex testing echoed these benefits, with multiple studies reporting cost savings from shorter hospital stays and reduced medication use.5Journal of Infection. Clinical impact of rapid multiplex testing for respiratory viruses: A systematic review and meta-analysis The practical upshot: the more precisely clinicians can identify a virus, the less likely they are to prescribe drugs that will not help.
Decongestants and What the Evidence Actually Shows
Over-the-counter decongestants are the first thing most people reach for when a cold plugs their nose. The evidence says they work, but modestly. A Cochrane review found that a single dose of a nasal decongestant reduced subjective congestion symptoms by about six percent compared to a placebo, supported by measurable decreases in airway resistance. With repeated doses over three to five days, the benefit shrank to roughly four percent. Adverse effects were relatively uncommon, though pseudoephedrine carried a small increased risk of insomnia.6Cochrane Database of Systematic Reviews. Nasal decongestants for the common cold
The difference between a helpful decongestant and a harmful one often comes down to how long you use it. Topical nasal sprays containing oxymetazoline or xylometazoline can cause rebound congestion, sometimes called drug-induced rhinitis, if used for more than a few consecutive days. The concentration, dose, frequency, and duration all determine whether this happens.7PubMed. Rise and fall of decongestants in treating nasal congestion related diseases Meanwhile, a separate Cochrane review noted that there was too little evidence to draw firm conclusions about whether oral or topical decongestants are more effective.8PubMed Central. Nasal decongestants in monotherapy for the common cold In practice, most clinicians recommend topical sprays for quick relief and oral decongestants for longer-lasting but gentler effects, with neither offering dramatic improvement.
Zinc Lozenges and the Dose That Matters
Zinc is one of the few supplements with consistent evidence behind it for cold duration, but the details matter a lot. A systematic review of randomized controlled trials found that zinc lozenges reduced cold duration by an average of about two days compared to placebo.9PubMed Central. Zinc Supplementation Reduces Common Cold Duration among Healthy Adults: A Systematic Review of Randomized Controlled Trials with Micronutrients Supplementation But not all zinc lozenges are equal. The type of zinc salt and the daily dose both influence how well they work. In trials using zinc acetate at daily doses above 75 mg, cold duration dropped by about 42 percent. Other zinc salts at similar doses produced a smaller reduction of around 20 percent.10PubMed Central. Zinc Lozenges May Shorten the Duration of Colds: A Systematic Review
A separate meta-analysis drilled into individual symptoms and found that high-dose zinc acetate lozenges shortened the duration of nasal congestion by about 37 percent, cough by 46 percent, and muscle ache by 54 percent. Effects on sore throat, sneezing, and scratchy throat were more modest, and there was no clear benefit for headache or fever.11PubMed Central. The effectiveness of high dose zinc acetate lozenges on various common cold symptoms: a meta-analysis The catch is that most drugstore zinc lozenges do not contain zinc acetate and often deliver doses well below the threshold where benefits appear. If you want to try zinc, check the label for the specific salt and total daily elemental zinc.
Saline Sprays Are Popular but Underwhelming
Saline nasal sprays are widely recommended as a gentle, drug-free way to relieve cold congestion. The evidence for them, however, is thin. A clinical trial comparing hypertonic saline spray, normal saline spray, and simple observation in subjects with colds or sinus infections found no meaningful difference between groups. The average day of feeling well again was similar across all three arms. Worse, about a third of participants using hypertonic saline reported a burning sensation, and fewer than half said they would use it again.12JAMA Network (Archives of Family Medicine). A clinical trial of hypertonic saline nasal spray in subjects with the common cold or rhinosinusitis Saline irrigation may still feel soothing and is unlikely to cause harm, but the expectation that it speeds recovery is not well supported.
The Antibiotic Problem
Nasopharyngitis is caused by viruses, and antibiotics do nothing against viruses. This is not new information, yet antibiotics continue to be prescribed for colds at strikingly high rates. A large French retrospective study spanning four years found that antibiotics were prescribed in about 16 percent of nasopharyngitis cases. Amoxicillin alone accounted for nearly 60 percent of those prescriptions, making it one of the most commonly dispensed drugs for a condition it cannot treat. Roughly a third of the antibiotics prescribed fell into the broader-spectrum “watch” category, meaning they are drugs public health authorities want reserved for more serious infections.13PubMed Central. Antibiotic prescriptions associated with a diagnosis of acute nasopharyngitis by general GPs in France: a retrospective study
Why does this keep happening? Patient expectations play a role. Many people visit a doctor believing they need a prescription and feel dissatisfied leaving without one. Physician time pressure contributes too; writing a prescription takes less time than explaining why one is not needed. The downstream consequences are not trivial. Unnecessary antibiotic use drives the development of resistant bacteria, increases the risk of side effects like diarrhea and allergic reactions, and adds cost without benefit.
When a Cold Becomes Something Else
Most colds resolve on their own, but occasionally the inflammation from a viral infection sets the stage for a secondary bacterial infection. Retained secretions in the nasopharynx are extremely common during an uncomplicated cold. In a subset of people, the initial viral infection and resulting swelling create closed-space conditions where bacteria that normally live harmlessly in the nose can proliferate and cause trouble.14PubMed Central. Otitis, Sinusitis, and Mastoiditis This is how a straightforward cold can evolve into acute sinusitis or a middle ear infection, particularly in young children whose anatomy makes them more susceptible. The warning signs that a cold may have crossed into bacterial territory include symptoms that worsen after an initial improvement, persistent high fever, or symptoms lasting well beyond the typical one-week window.
Sleep and Your Cold Risk
One of the more striking findings in cold research is how powerfully sleep affects your susceptibility. In a study that deliberately exposed volunteers to rhinovirus and then tracked who got sick, people sleeping fewer than five hours a night were roughly four and a half times more likely to develop a clinical cold than those sleeping seven hours or more. Even sleeping five to six hours nearly quadrupled the risk. Sleeping just above six hours offered no significantly increased risk compared to the seven-hour group.15PubMed Central. Behaviorally Assessed Sleep and Susceptibility to the Common Cold This was measured using wrist-worn activity trackers rather than self-report, giving the findings more weight.
An earlier study using the same deliberate-exposure design found that both sleep duration and sleep efficiency, meaning the proportion of time in bed actually spent asleep, predicted cold risk. When both were entered into the same analysis, sleep efficiency was the stronger predictor. People with the lowest sleep efficiency were over five times more likely to develop a cold than those with the highest.16PubMed Central. Sleep Habits and Susceptibility to the Common Cold Tossing and turning matters, not just hours in bed.
Why Cold Weather Actually Helps the Virus
The folk wisdom that cold weather causes colds is not exactly right, but it is not entirely wrong either. Rhinoviruses replicate best at around 33°C, which happens to be the temperature inside your nose on a cool day. Your core body temperature of 37°C is less hospitable to the virus. Research using mouse airway cells demonstrated why: at the warmer temperature, infected cells mounted a more robust antiviral defense, secreting more interferons and activating stronger antiviral gene expression. At the cooler temperature, this defense was blunted, and the virus replicated more freely.17PubMed Central. Temperature-dependent innate defense against the common cold virus limits viral replication at warm temperature in mouse airway cells Cold air does not introduce the virus, but it tilts the battle inside your nasal passages in the virus’s favor by cooling the airway surface and weakening local immune responses.
Your Nasal Bacteria May Shape How Sick You Get
Emerging research suggests that the community of bacteria living in your nose before a cold virus arrives influences how severe your symptoms become. In an experimental rhinovirus challenge study, researchers clustered participants by their baseline nasal microbiota profiles. People whose nasal bacteria were dominated by certain bacterial types experienced milder cold symptoms than those with profiles rich in staphylococci or mixed communities.18PubMed Central. Nasal microbiota clusters associate with inflammatory response, viral load, and symptom severity in experimental rhinovirus challenge
A study of school-age children took this further by examining not just bacteria but also bacteriophages, the viruses that infect bacteria. Children whose nasal profiles were dominated by healthy commensal bacteria had significantly lower odds of developing respiratory viral infections. By contrast, children with profiles dominated by phages had nearly four times the odds. The most protective commensal bacterium identified was one that the phages appeared to suppress, creating an indirect pathway through which the viral environment in the nose could raise cold risk.19PubMed Central. Nasal microbiome and phageome profiles are associated with prospective respiratory viral infection risk in school-age children This line of research is still young, but it raises the possibility that maintaining a healthy nasal microbiome, perhaps by avoiding unnecessary nasal antibiotics, could influence how often and how severely you catch colds.
Athletes Get More Colds Than You Would Expect
You might assume that elite athletes, with their rigorous fitness and access to sports medicine, would rarely catch colds. The opposite tends to be true. During periods of intense training and competition, athletes are actually more prone to upper respiratory infections. In a controlled study of an elite winter sports team, 38 percent of athletes reported symptoms of respiratory infection during the study period, compared to 17 percent of staff members. Symptoms lasted about five to six days in both groups and were overwhelmingly mild, with not a single team member developing a fever.20PLoS ONE. Increased risk of respiratory viral infections in elite athletes: A controlled study
The pattern is somewhat paradoxical. Heavy training temporarily suppresses certain immune functions, which would suggest athletes should get sicker, not just more often. Yet viral loads in athletes tend to be low, viral shedding is short, and bacterial complications are rare. Antibiotic treatment is seldom warranted. Symptoms last roughly five to nine days, in line with the general population, though about 20 percent of infections in elite skiers were entirely asymptomatic.21PubMed Central. Respiratory Viral Infections in Athletes: Many Unanswered Questions The bigger concern for competitive athletes is not danger but disruption: even a mild cold can degrade performance at the margins that separate medalists from the rest of the field.
Prevention Beyond Hand Washing
Hand hygiene remains the most accessible preventive measure against colds, and combining it with face masks may offer additional protection. A cluster randomized trial found that when masks and hand hygiene were implemented within 36 hours of symptom onset in a household member, secondary transmission of confirmed respiratory infections dropped substantially.22PubMed. Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial The timing mattered: the intervention was effective only when started early, before the virus had already spread to other household members.
A vaccine for the common cold remains elusive. The core obstacle is the sheer number of rhinovirus serotypes, with over a hundred known variants, and the fact that immunity to one does not protect against others.23PubMed Central. Developing a vaccine for human rhinoviruses Unlike influenza, where a handful of circulating strains can be targeted each season, rhinovirus diversity makes a single vaccine impractical with current technology. Several research groups are working on approaches that target conserved regions of the virus shared across serotypes, but none has reached clinical use.
The Economic Weight of a “Minor” Illness
Because nasopharyngitis is not dangerous, its economic impact tends to be underestimated. A U.S. analysis estimated that each cold experienced by a working adult caused an average of 8.7 lost work hours, most of which came not from staying home but from reduced productivity while on the job. The total economic cost of lost productivity from colds was estimated at roughly $25 billion annually, with on-the-job productivity loss accounting for the largest share at about $16.6 billion. Absenteeism added another $8 billion, and caregiver time for sick children contributed $230 million more.24PubMed. Productivity losses related to the common cold These figures predate the current era and have likely grown with wage inflation, but the structural point holds: the common cold’s real cost is not in medical bills but in millions of people working at reduced capacity, all at once, several times a year.